wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5
Q33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
P2860
Q33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d61287e6fd7afce571c87c126e8087c1c973eeaf
P2860
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.